Canada Markets closed

ORAN Aug 2022 12.500 call

OPR - OPR Delayed Price. Currency in USD
Add to watchlist
0.04000.0000 (0.00%)
As of 03:30PM EDT. Market open.
Full screen
Loading interactive chart...
  • GlobeNewswire

    Total number of shares and voting rights at July 31, 2022

    8 August 2022 Orange: information on the total number of shares and voting rights referred to in Article L.233-8 II of the French Commercial Code and Article 223-16 of the General Regulations of the Autorité des Marchés Financiers. In application of Article L. 22-10-46 of the French Commercial Code (Code de commerce), as from 3 April 2016, a double voting right is automatically granted to fully paid-up shares that have been held in registered form and under a single shareholder name for at least

  • GlobeNewswire

    Orange: Publication of 2022 interim financial report

    Press release Paris, 1 August 2022 *Orange announces the publication of its first half 2022 financial report. The report was filed with the French Financial Markets Authority (AMF) and submitted to the U.S. Securities and Exchange Commission. It is available on the website of the Company at the following address: https://www.orange.com/en/regulated-information About Orange Orange is one of the world’s leading telecommunications operators with sales of 42.5 billion euros in 2021 and 137,000 emplo

  • Reuters

    Orange shares spooked by drop in enterprise earnings

    PARIS (Reuters) -Shares in Orange SA, France's biggest telecom firm, fell on Thursday as investors worried about a plunge in first-half profits at its enterprise and IT services division. The stock was down more than 3% at 0751 GMT, the third-worst performer on France's blue chip index, despite the group reporting second-quarter results in line with analyst forecasts. Orange said its enterprise division saw core operating profit, or EBITDAaL, drop more than 25% in the first half from a year earlier, fuelling concerns over the group's ability to reach its full-year profit targets, which it confirmed.